about
The relationship between blood pressure and painProtein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis.Alterations of intestinal barrier and microbiota in chronic kidney disease.The relation between the incidence of hypernatremia and mortality in patients with severe traumatic brain injury.Severe hypomagnesemia during long-term treatment with a proton pump inhibitor.Specialized nutritional support interventions in critically ill patients on renal replacement therapy.Protein/energy debt in critically ill children in the pediatric intensive care unit: acute kidney injury as a major risk factor.Intradialytic parenteral nutrition in end-stage renal disease: practical aspects, indications and limits.Hyper/hypoglycemia and acute kidney injury in critically ill patients.Colistin Use in Patients With Reduced Kidney Function.Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.Barriers to physical activity in chronic hemodialysis patients: a single-center pilot study in an Italian dialysis facility.Specific nutritional problems in acute kidney injury, treated with non-dialysis and dialytic modalities.Severe acute kidney injury following cardiac surgery: short-term outcomes in patients undergoing continuous renal replacement therapy (CRRT).Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH.Energy and Protein in Critically Ill Patients with AKI: A Prospective, Multicenter Observational Study Using Indirect Calorimetry and Protein Catabolic Rate.Myeloperoxidase-Related Chlorination Activity Is Positively Associated with Circulating Ceruloplasmin in Chronic Heart Failure Patients: Relationship with Neurohormonal, Inflammatory, and Nutritional Parameters.Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma.Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: results from a pilot study in elderly chronic heart failure patients.Cerebral perfusion during intermittent hemodialysis in patients with acute kidney injury and advanced liver cirrhosis.Low serum ferroxidase I activity is associated with mortality in heart failure and related to both peroxynitrite-induced cysteine oxidation and tyrosine nitration of ceruloplasmin.Recent advances in the pathogenetic mechanisms of sepsis-associated acute kidney injury.Cerebral blood flow decreases during intermittent hemodialysis in patients with acute kidney injury, but not in patients with end-stage renal disease.Diet and enteral nutrition in patients with chronic kidney disease not on dialysis: a review focusing on fat, fiber and protein intake.Acute kidney injury and stroke: unresolved issues.Serum adipokine zinc α2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers.Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).Treatment of Metformin Intoxication Complicated by Lactic Acidosis and Acute Kidney Injury: The Role of Prolonged Intermittent Hemodialysis.Ultrafiltration in acute decompensated heart failure: friend or foe for the kidney?Renal resistive index by transesophageal and transparietal echo-doppler imaging for the prediction of acute kidney injury in patients undergoing major heart surgery.Preventing Continuous Renal Replacement Therapy-Induced Hypophosphatemia: An Extended Clinical Experience with a Phosphate-Containing Solution in the Setting of Regional Citrate Anticoagulation.Reliability of bedside ultrasound for measurement of quadriceps muscle thickness in critically ill patients with acute kidney injury.Interaction of healthcare staff's attitude with barriers to physical activity in hemodialysis patients: A quantitative assessment.Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study.Correction: Interaction of healthcare staff's attitude with barriers to physical activity in hemodialysis patients: A quantitative assessment.Noninvasive evaluation of muscle mass by ultrasonography of quadriceps femoris muscle in End-Stage Renal Disease patients on hemodialysisEffects of the radiocontrast agent iodixanol on endothelial cell morphology and functionA clinical phenotype mimicking essential hypertension in a newly discovered family with Liddle's syndromeIntraprocedural cortisol measurement increases adrenal vein sampling success rate in primary aldosteronismBalancing thromboembolic risk against vitamin K antagonist-related bleeding and accelerated calcification: is fondaparinux the Holy Grail for end-stage renal disease patients with atrial fibrillation?
P50
Q27026888-B5937AA0-06B1-43BD-94EB-A19562C921F4Q30249187-24F7921E-2EA0-40E3-9C56-A5D5537ADD1DQ35239148-47617CE6-367B-4909-AF23-890058A127CBQ37360294-C953508A-1BE1-44A1-9123-AF38B02C736BQ37759520-7CEA648D-5DD4-4DAE-8CFB-35A8AC10AF7CQ38067598-3C2BE598-C1C9-4B49-ACAC-DFFE92E082B8Q38161681-74C76B08-9110-4D30-807B-0F31E4DB05E4Q38190040-ADCFA7E2-413C-4BE5-9635-AC8FF85CF72EQ38442063-D2FF75B0-3C10-4BA3-9E24-3BA68AC7259EQ38829796-36C57F14-B38D-43F3-8DEC-D8B601E08C27Q38921854-1DEEA508-FD39-4BF2-B939-21F89F530E3EQ39145656-83A65DEA-9991-4977-BE8A-22DA465659F9Q40333259-05EE3B48-9976-4563-A74E-E869EE5F2AF5Q41196531-C128796A-93D2-49C3-8281-D64759E1CEE8Q41376026-98BC1D1B-3A61-476A-80C3-A13A2AA3A3C7Q41583761-666A3E3B-BB25-4B95-A79E-09A0D84EC6B7Q41871114-E9514946-B223-4D67-9874-EF1036A4830CQ44117739-A8AD79A1-32A0-482D-B77F-BC67F98FEF2CQ44590285-DAF535D5-063D-40DC-9503-A4BA8AC7C1FAQ46673701-9FEAADB0-1745-4B4E-936E-A0F65A7ED0D5Q46911832-33301263-926A-4BCF-8F52-D4D089FE898BQ47255833-F2509D11-9870-43E6-AFC7-FF621C4FC897Q47605205-AC7DC11D-E367-4451-8677-5874F133711CQ47836803-7095EB5A-2FA7-444F-B6C5-3D8F007FF405Q48137238-37EDF3C3-B5CA-4391-A325-6876258EF14FQ49139351-FC2ECE85-5D19-4F0F-ACB7-312E98B39FE9Q49893436-9E90A56B-0EDA-4CB5-BBC3-75914A99BF77Q50880186-FDEAAEAB-F211-4239-BD61-9A33A106F122Q51812717-5FC99E0F-582F-4719-8D38-20C05E758875Q53142803-3F3F8308-6627-45B5-ADF9-48FB870A1E89Q53913249-8CE8DEAE-2899-4058-BC32-165499503BDFQ54551292-21913B80-738D-4081-8FAA-D914756E3D33Q54940111-849A3588-A81F-431E-950A-B056887B865DQ55070146-FC630801-2765-4161-A956-711251F786D6Q55490821-ED6831C4-E8D6-49DF-84E6-1B0DB7D5ACA2Q58280804-9DF9F62E-D544-4973-BCFA-A6041CE8B309Q62029322-C54F5A25-4C65-4335-BB61-366C428F132DQ83987131-10F81D9E-44B2-487B-BE02-22FB1E05C76AQ84784390-6F334A9C-337B-40BC-A33C-4F3001FD7A6AQ85735098-62DD2A75-67FE-4A90-8923-85168C9442A9
P50
description
investigador
@es
researcher
@en
name
Giuseppe Regolisti
@en
type
label
Giuseppe Regolisti
@en
prefLabel
Giuseppe Regolisti
@en
P31
P496
0000-0002-9976-5681